Clinical Trials
3 trialsNCT07310784 2026-05-12
A Phase II Trial of LM103 in Advanced Melanoma
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase 2 Recruiting
NCT03407170 2020-07-15
KEYNOTE-161
Merck Sharp & Dohme LLC
Phase 2 Terminated
NCT03818893 2019-01-30
Combination Therapy With GEN0101 and Pembrolizmub in Advanced Melanoma Patients PIb/PII
Osaka University
Phase 2 Unknown